In addition, mutations in human BUB1B have demonstrated a dominant negative effect by disrupting the mitotic checkpoint when transfected into euploid colon cancer cell lines (Davenport et al. 1999). This evidence concerns the gene BUB1B and malignant colon neoplasm.